BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35365098)

  • 1. Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.
    Moisoiu T; Dragomir MP; Iancu SD; Schallenberg S; Birolo G; Ferrero G; Burghelea D; Stefancu A; Cozan RG; Licarete E; Allione A; Matullo G; Iacob G; Bálint Z; Badea RI; Naccarati A; Horst D; Pardini B; Leopold N; Elec F
    Mol Med; 2022 Apr; 28(1):39. PubMed ID: 35365098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
    Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
    BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes.
    Pardini B; Cordero F; Naccarati A; Viberti C; Birolo G; Oderda M; Di Gaetano C; Arigoni M; Martina F; Calogero RA; Sacerdote C; Gontero P; Vineis P; Matullo G
    Oncotarget; 2018 Apr; 9(29):20658-20669. PubMed ID: 29755679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors.
    Strømme O; Heck KA; Brede G; Lindholm HT; Otterlei M; Arum CJ
    Curr Issues Mol Biol; 2021 Jun; 43(1):286-300. PubMed ID: 34199766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.
    Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L
    Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNA panels for specific and early detection in bladder cancer.
    Usuba W; Urabe F; Yamamoto Y; Matsuzaki J; Sasaki H; Ichikawa M; Takizawa S; Aoki Y; Niida S; Kato K; Egawa S; Chikaraishi T; Fujimoto H; Ochiya T
    Cancer Sci; 2019 Jan; 110(1):408-419. PubMed ID: 30382619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma microRNA profiles for bladder cancer detection.
    Adam L; Wszolek MF; Liu CG; Jing W; Diao L; Zien A; Zhang JD; Jackson D; Dinney CP
    Urol Oncol; 2013 Nov; 31(8):1701-8. PubMed ID: 22863868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
    Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
    Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Du L; Jiang X; Duan W; Wang R; Wang L; Zheng G; Yan K; Wang L; Li J; Zhang X; Pan H; Yang Y; Wang C
    Oncotarget; 2017 Jun; 8(25):40832-40842. PubMed ID: 28388561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
    El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W
    Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
    BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
    Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
    Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profile of microRNAs (106b-3p, 130b-3, 145-3p, 199a-5p) in urine and serum samples from patients with the diagnosis of bladder cancer.
    Kutwin P; Borkowska EM; Bogucka P; Jabłonowski Z
    Pol Merkur Lekarski; 2021 Apr; 49(290):103-107. PubMed ID: 33895754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SERS Liquid Biopsy Profiling of Serum for the Diagnosis of Kidney Cancer.
    Moisoiu T; Iancu SD; Burghelea D; Dragomir MP; Iacob G; Stefancu A; Cozan RG; Antal O; Bálint Z; Muntean V; Badea RI; Licarete E; Leopold N; Elec FI
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine.
    Lin JT; Tsai KW
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.